aluates Reports

$ 0.0

Automative

Global Human Milk Oligosaccharides (HMO) Market Research Report 2026

Published Date: 2026-02-10

Report Code: QYRE-Auto-2252

Global Human Milk Oligosaccharides HMO Market Insights and Forecast to 2028

BUY CHAPTERS

Global Human Milk Oligosaccharides (HMO) Market Research Report 2026

Code: QYRE-Auto-2252

Report

2026-02-10

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott

Inbiose

Glycom

ZuChem

Chr. Hansen (Jennewein)

Elicityl SA

Human Milk Oligosaccharides (HMO) Market Size

The global Human Milk Oligosaccharides (HMO) market was valued at US$ 864 million in 2025 and is anticipated to reach US$ 3938 million by 2032, at a CAGR of 24.6% from 2026 to 2032.

Human Milk Oligosaccharides (HMO) Market

Human Milk Oligosaccharides (HMO) are a class of complex carbohydrates naturally found in human breast milk. They are composed of multiple sugar units linked by glycosidic bonds. HMOs are one of the most abundant components in human milk after fat, protein, and lactose, and their concentration is significantly higher in human milk compared to other mammals. HMOs play a crucial role in infant health, serving as prebiotics that promote the growth of beneficial bacteria, such as bifidobacteria, helping to establish a healthy gut microbiome and enhance immune system function.

HMOs vary in structure, including monosaccharides, disaccharides, trisaccharides, and longer polysaccharide chains. Different types of HMOs have distinct biological functions, helping to combat pathogen invasion, reduce inflammation, and support brain development. While HMOs are primarily found in human milk, advances in technology have made it possible to extract and synthesize these oligosaccharides through fermentation and chemical processes for use in commercial products like infant formula, functional foods, and health supplements.

With ongoing research into the benefits of HMOs in infant health and other wellness applications, the demand for human milk oligosaccharides has been steadily increasing, particularly in infant formula and adult prebiotic foods.

Market Development Opportunities and Key Drivers:

As consumer awareness of health increases, especially in regard to infant health, the market for human milk oligosaccharides (HMOs) is experiencing significant growth opportunities. In recent years, extensive research on the role of HMOs in infant health has led more infant formula manufacturers to incorporate HMOs into their products to support immune function and gut health. Additionally, HMOs have shown potential in adult health applications, particularly in maintaining gut microbiome balance and enhancing immune function, opening new growth avenues for the market. As the global population ages and the demand for functional foods rises, there is also growing demand for prebiotic products targeting adults.

Market Risks:

Despite the promising outlook for the HMO market, there are several risks. First, the production of HMOs is complex and costly, which may hinder product accessibility and price competitiveness. Second, the HMO supply chain is intricate, involving multiple stages such as raw material extraction and fermentation. Any technological challenges or disruptions in production could affect the stability of the entire supply chain. Moreover, global regulatory and standard differences may pose challenges to market expansion, particularly in terms of varying regulatory policies and certification requirements in different countries.

Market Concentration:

Currently, the HMO production market is relatively concentrated, with several leading biotech and pharmaceutical companies dominating the industry. These companies have advanced fermentation and biosynthesis technologies that enable large-scale production while maintaining high quality. However, as technology advances and the market expands, more small and medium-sized enterprises are expected to enter the market, fostering competition and innovation.

Downstream Demand Trends:

The downstream demand for HMOs is mainly concentrated in infant formula, prebiotic foods and supplements, and personalized nutrition products. As consumers increasingly demand personalized and functional nutrition products, the market for HMOs as a functional ingredient will continue to grow. Additionally, the potential for HMOs in aging populations is being recognized, particularly for supporting gut health and immune systems in elderly individuals.

Latest Technologies:

The production technology for HMOs is continually evolving, with innovations in fermentation and biosynthesis reducing production costs. Furthermore, the application of genetic engineering and synthetic biology has opened up possibilities for customized HMO production, allowing for optimized efficiency and yields through genetically modified microorganisms.

This report delivers a comprehensive overview of the global Human Milk Oligosaccharides (HMO) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Milk Oligosaccharides (HMO). The Human Milk Oligosaccharides (HMO) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Human Milk Oligosaccharides (HMO) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Human Milk Oligosaccharides (HMO) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Human Milk Oligosaccharides (HMO) Market Report

Report Metric	Details
Report Name	Human Milk Oligosaccharides (HMO) Market
Accounted market size in 2025	US$ 864 million
Forecasted market size in 2032	US$ 3938 million
CAGR	24.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	2'-FL & 3-FL LNT & LNnT, etc.
Segment by Application	Infant Formula Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Human Milk Oligosaccharides (HMO) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Human Milk Oligosaccharides (HMO) Market growing?

Ans: The Human Milk Oligosaccharides (HMO) Market witnessing a CAGR of 24.6% during the forecast period 2026-2032.

What is the Human Milk Oligosaccharides (HMO) Market size in 2032?

Ans: The Human Milk Oligosaccharides (HMO) Market size in 2032 will be US$ 3938 million.

Who are the main players in the Human Milk Oligosaccharides (HMO) Market report?

Ans: The main players in the Human Milk Oligosaccharides (HMO) Market are Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem

What are the Application segmentation covered in the Human Milk Oligosaccharides (HMO) Market report?

Ans: The Applications covered in the Human Milk Oligosaccharides (HMO) Market report are Infant Formula, Others

What are the Type segmentation covered in the Human Milk Oligosaccharides (HMO) Market report?

Ans: The Types covered in the Human Milk Oligosaccharides (HMO) Market report are 2'-FL & 3-FL, LNT & LNnT, etc.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 2'-FL & 3-FL

1.2.3 LNT & LNnT, etc.

1.3 Market by Application

1.3.1 Global Human Milk Oligosaccharides (HMO) Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Infant Formula

1.3.3 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Human Milk Oligosaccharides (HMO) Market Perspective (2021–2032)

2.2 Global Human Milk Oligosaccharides (HMO) Growth Trends by Region

2.2.1 Global Human Milk Oligosaccharides (HMO) Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Human Milk Oligosaccharides (HMO) Historic Market Size by Region (2021–2026)

2.2.3 Human Milk Oligosaccharides (HMO) Forecasted Market Size by Region (2027–2032)

2.3 Human Milk Oligosaccharides (HMO) Market Dynamics

2.3.1 Human Milk Oligosaccharides (HMO) Industry Trends

2.3.2 Human Milk Oligosaccharides (HMO) Market Drivers

2.3.3 Human Milk Oligosaccharides (HMO) Market Challenges

2.3.4 Human Milk Oligosaccharides (HMO) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Human Milk Oligosaccharides (HMO) Players by Revenue

3.1.1 Global Top Human Milk Oligosaccharides (HMO) Players by Revenue (2021–2026)

3.1.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Players (2021–2026)

3.2 Global Top Human Milk Oligosaccharides (HMO) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Human Milk Oligosaccharides (HMO) Revenue

3.4 Global Human Milk Oligosaccharides (HMO) Market Concentration Ratio

3.4.1 Global Human Milk Oligosaccharides (HMO) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human Milk Oligosaccharides (HMO) Revenue in 2025

3.5 Global Key Players of Human Milk Oligosaccharides (HMO) Head Offices and Areas Served

3.6 Global Key Players of Human Milk Oligosaccharides (HMO), Products and Applications

3.7 Global Key Players of Human Milk Oligosaccharides (HMO), Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Human Milk Oligosaccharides (HMO) Breakdown Data by Type

4.1 Global Human Milk Oligosaccharides (HMO) Historic Market Size by Type (2021–2026)

4.2 Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Type (2027–2032)

5 Human Milk Oligosaccharides (HMO) Breakdown Data by Application

5.1 Global Human Milk Oligosaccharides (HMO) Historic Market Size by Application (2021–2026)

5.2 Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Human Milk Oligosaccharides (HMO) Market Size (2021–2032)

6.2 North America Human Milk Oligosaccharides (HMO) Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Human Milk Oligosaccharides (HMO) Market Size by Country (2021–2026)

6.4 North America Human Milk Oligosaccharides (HMO) Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Human Milk Oligosaccharides (HMO) Market Size (2021–2032)

7.2 Europe Human Milk Oligosaccharides (HMO) Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Human Milk Oligosaccharides (HMO) Market Size by Country (2021–2026)

7.4 Europe Human Milk Oligosaccharides (HMO) Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size (2021–2032)

8.2 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Region (2021–2026)

8.4 Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Human Milk Oligosaccharides (HMO) Market Size (2021–2032)

9.2 Latin America Human Milk Oligosaccharides (HMO) Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Human Milk Oligosaccharides (HMO) Market Size by Country (2021–2026)

9.4 Latin America Human Milk Oligosaccharides (HMO) Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size (2021–2032)

10.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size by Country (2021–2026)

10.4 Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Human Milk Oligosaccharides (HMO) Introduction

11.1.4 Abbott Revenue in Human Milk Oligosaccharides (HMO) Business (2021–2026)

11.1.5 Abbott Recent Development

11.2 Inbiose

11.2.1 Inbiose Company Details

11.2.2 Inbiose Business Overview

11.2.3 Inbiose Human Milk Oligosaccharides (HMO) Introduction

11.2.4 Inbiose Revenue in Human Milk Oligosaccharides (HMO) Business (2021–2026)

11.2.5 Inbiose Recent Development

11.3 Glycom

11.3.1 Glycom Company Details

11.3.2 Glycom Business Overview

11.3.3 Glycom Human Milk Oligosaccharides (HMO) Introduction

11.3.4 Glycom Revenue in Human Milk Oligosaccharides (HMO) Business (2021–2026)

11.3.5 Glycom Recent Development

11.4 Chr. Hansen (Jennewein)

11.4.1 Chr. Hansen (Jennewein) Company Details

11.4.2 Chr. Hansen (Jennewein) Business Overview

11.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Introduction

11.4.4 Chr. Hansen (Jennewein) Revenue in Human Milk Oligosaccharides (HMO) Business (2021–2026)

11.4.5 Chr. Hansen (Jennewein) Recent Development

11.5 Elicityl SA

11.5.1 Elicityl SA Company Details

11.5.2 Elicityl SA Business Overview

11.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Introduction

11.5.4 Elicityl SA Revenue in Human Milk Oligosaccharides (HMO) Business (2021–2026)

11.5.5 Elicityl SA Recent Development

11.6 ZuChem

11.6.1 ZuChem Company Details

11.6.2 ZuChem Business Overview

11.6.3 ZuChem Human Milk Oligosaccharides (HMO) Introduction

11.6.4 ZuChem Revenue in Human Milk Oligosaccharides (HMO) Business (2021–2026)

11.6.5 ZuChem Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott

Inbiose

Glycom

ZuChem

Chr. Hansen (Jennewein)

Elicityl SA

List of Tables

Table 1. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of 2'-FL & 3-FL

Table 3. Key Players of LNT & LNnT, etc.

Table 4. Global Human Milk Oligosaccharides (HMO) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million), 2021–2026

Table 7. Global Human Milk Oligosaccharides (HMO) Market Share by Region (2021–2026)

Table 8. Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Human Milk Oligosaccharides (HMO) Market Share by Region (2027–2032)

Table 10. Human Milk Oligosaccharides (HMO) Market Trends

Table 11. Human Milk Oligosaccharides (HMO) Market Drivers

Table 12. Human Milk Oligosaccharides (HMO) Market Challenges

Table 13. Human Milk Oligosaccharides (HMO) Market Restraints

Table 14. Global Human Milk Oligosaccharides (HMO) Revenue by Players (US$ Million), 2021–2026

Table 15. Global Human Milk Oligosaccharides (HMO) Market Share by Players (2021–2026)

Table 16. Global Top Human Milk Oligosaccharides (HMO) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Human Milk Oligosaccharides (HMO) Revenue, 2025

Table 17. Ranking of Global Top Human Milk Oligosaccharides (HMO) Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Human Milk Oligosaccharides (HMO) Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Human Milk Oligosaccharides (HMO), Headquarters and Area Served

Table 20. Global Key Players of Human Milk Oligosaccharides (HMO), Products and Applications

Table 21. Global Key Players of Human Milk Oligosaccharides (HMO), Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Human Milk Oligosaccharides (HMO) Market Size by Type (US$ Million), 2021–2026

Table 24. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2021–2026)

Table 25. Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2027–2032)

Table 27. Global Human Milk Oligosaccharides (HMO) Market Size by Application (US$ Million), 2021–2026

Table 28. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2021–2026)

Table 29. Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2027–2032)

Table 31. North America Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Human Milk Oligosaccharides (HMO) Market Size by Country (US$ Million), 2021–2026

Table 33. North America Human Milk Oligosaccharides (HMO) Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Human Milk Oligosaccharides (HMO) Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Human Milk Oligosaccharides (HMO) Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Human Milk Oligosaccharides (HMO) Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Human Milk Oligosaccharides (HMO) Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size by Country (US$ Million), 2027–2032

Table 46. Abbott Company Details

Table 47. Abbott Business Overview

Table 48. Abbott Human Milk Oligosaccharides (HMO) Product

Table 49. Abbott Revenue in Human Milk Oligosaccharides (HMO) Business (US$ Million), 2021–2026

Table 50. Abbott Recent Development

Table 51. Inbiose Company Details

Table 52. Inbiose Business Overview

Table 53. Inbiose Human Milk Oligosaccharides (HMO) Product

Table 54. Inbiose Revenue in Human Milk Oligosaccharides (HMO) Business (US$ Million), 2021–2026

Table 55. Inbiose Recent Development

Table 56. Glycom Company Details

Table 57. Glycom Business Overview

Table 58. Glycom Human Milk Oligosaccharides (HMO) Product

Table 59. Glycom Revenue in Human Milk Oligosaccharides (HMO) Business (US$ Million), 2021–2026

Table 60. Glycom Recent Development

Table 61. Chr. Hansen (Jennewein) Company Details

Table 62. Chr. Hansen (Jennewein) Business Overview

Table 63. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product

Table 64. Chr. Hansen (Jennewein) Revenue in Human Milk Oligosaccharides (HMO) Business (US$ Million), 2021–2026

Table 65. Chr. Hansen (Jennewein) Recent Development

Table 66. Elicityl SA Company Details

Table 67. Elicityl SA Business Overview

Table 68. Elicityl SA Human Milk Oligosaccharides (HMO) Product

Table 69. Elicityl SA Revenue in Human Milk Oligosaccharides (HMO) Business (US$ Million), 2021–2026

Table 70. Elicityl SA Recent Development

Table 71. ZuChem Company Details

Table 72. ZuChem Business Overview

Table 73. ZuChem Human Milk Oligosaccharides (HMO) Product

Table 74. ZuChem Revenue in Human Milk Oligosaccharides (HMO) Business (US$ Million), 2021–2026

Table 75. ZuChem Recent Development

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

Table 79. Authors List of This Report

List of Figures

Figure 1. Human Milk Oligosaccharides (HMO) Picture

Figure 2. Global Human Milk Oligosaccharides (HMO) Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Human Milk Oligosaccharides (HMO) Market Share by Type: 2025 vs 2032

Figure 4. 2'-FL & 3-FL Features

Figure 5. LNT & LNnT, etc. Features

Figure 6. Global Human Milk Oligosaccharides (HMO) Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Human Milk Oligosaccharides (HMO) Market Share by Application: 2025 vs 2032

Figure 8. Infant Formula Case Studies

Figure 9. Others Case Studies

Figure 10. Human Milk Oligosaccharides (HMO) Report Years Considered

Figure 11. Global Human Milk Oligosaccharides (HMO) Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 12. Global Human Milk Oligosaccharides (HMO) Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Human Milk Oligosaccharides (HMO) Market Share by Region: 2025 vs 2032

Figure 14. Global Human Milk Oligosaccharides (HMO) Market Share by Players in 2025

Figure 15. Global Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by Human Milk Oligosaccharides (HMO) Revenue in 2025

Figure 17. North America Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 18. North America Human Milk Oligosaccharides (HMO) Market Share by Country (2021–2032)

Figure 19. United States Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. Canada Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Europe Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Human Milk Oligosaccharides (HMO) Market Share by Country (2021–2032)

Figure 23. Germany Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. France Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. U.K. Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Italy Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Russia Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Ireland Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share by Region (2021–2032)

Figure 31. China Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Japan Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. South Korea Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Southeast Asia Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. India Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Australia & New Zealand Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Latin America Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Human Milk Oligosaccharides (HMO) Market Share by Country (2021–2032)

Figure 39. Mexico Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Brazil Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Human Milk Oligosaccharides (HMO) Market Share by Country (2021–2032)

Figure 43. Israel Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Saudi Arabia Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. UAE Human Milk Oligosaccharides (HMO) Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Abbott Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2021–2026)

Figure 47. Inbiose Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2021–2026)

Figure 48. Glycom Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2021–2026)

Figure 49. Chr. Hansen (Jennewein) Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2021–2026)

Figure 50. Elicityl SA Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2021–2026)

Figure 51. ZuChem Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2021–2026)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Milk Oligosaccharides in Infant Formula Market Research Report 2024

Global Biosynthetic Human Milk Oligosaccharides HMOs Market Research Report 2025

Global Sialylated Human Milk Oligosaccharides HMO Market Research Report 2024

Global HMO Infant Formula Market Research Report 2025

Global 6 Sialyllactose 6 SL Market Research Report 2024

Global Oligosaccharides in Infant Nutrition Market Insights Forecast to 2030

Oligosaccharide for Infant Formula Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lacto N tetraose LNT and Lacto N neotetraose LNnT Market Research Report 2024

Global Trans galactooligosaccharides Market Research Report 2024

Global Galacto oligosaccharide Market Research Report 2025

Global Mannan oligosaccharide MOS Market Research Report 2024

Global Bifidobacterium Infantis Market Research Report 2024

Global Oligosaccharide Market Research Report 2025

Global HMO Children s Milk Powder Market Research Report 2024

Galacto oligosaccharid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Galacto Oligosaccharides GOS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bifidobacterium Longum Subsp Infantis M 63 Market Research Report 2024

Global Xylo oligosaccharide XOS Market Insights Forecast to 2030

Global HMO Children s Formula Milk Powder Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions